BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  China

  Choosing China: Akeso’s $3M Beginnings and the Rise of China’s Biotech Sector

  From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today.

  September 17, 2025

   · 

  8 min read

   · 

  Tristan Manalac
• 

  Career Advice

  Stop Selling the Dream, Start Telling the Truth

  Transparency doesn’t drive people away. It attracts the right ones and keeps them committed. Leadership coach Angela Justice discusses the problem with leaders only selling the upside and the value of setting accurate expectations from the start.

  September 17, 2025

   · 

  3 min read

   · 

  Angela Justice
• 

  Obesity

  Lilly Paints ‘Competitive Profile’ for Obesity Pill With Detailed Late-Stage Data

  The over-representation of males and Hispanic patients in Eli Lilly’s Phase III ATTAIN-1 study could explain why orforglipron “underperformed” expectations in a previous readout, according to analysts at BMO Capital Markets.

  September 17, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  Lilly to Bring Nearly 2,500 Jobs to Virginia With $5B Manufacturing Plant

  This manufacturing site in Richmond, Virginia, is the first of four projects that Eli Lilly plans to reveal this year as part of a $27 billion U.S. investment announced earlier this year.

  September 17, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  Startups

  Ollin Emerges From Stealth With $100M To Develop Eye Disease Bispecifics

  OLN324 targets both VEGF and Ang2, the same mechanism of action as Roche’s Vabysmo, the Swiss giant’s multi-blockbuster treatment for wet macular degeneration and diabetic macular edema.

  September 17, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Manufacturing

  GSK Commits $30B To Boost US R&D, Manufacturing Operations

  The multi-billion, multi-year investment comes as many of GSK’s pharma peers pull away from the U.K., either suspending or completely canceling previous commitments.

  September 17, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  FDA

  FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s

  In letters to Eli Lilly and Novo Nordisk, the FDA accused the companies of downplaying the risks of their GLP-1 weight loss drugs during a prime time special with Oprah Winfrey.

  September 17, 2025

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Layoffs

  Innate Sheds 30% of Staff, Narrows Pipeline Focus Amid ‘Challenging Funding Environment’

  Moving forward, Innate will focus on the clinical development of its antibody-drug conjugate IPH4502, the lymphoma candidate lacutamab and the AstraZeneca-partnered monalizumab.

  September 17, 2025

   · 

  1 min read

   · 

  Tristan Manalac
• 

  IN PARTNERSHIP WITH Pii, A JABIL COMPANY

  Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing

  Listen now for a high-level discussion on overcoming pharmaceutical supply chain challenges through end-to-end integration.
  

  September 17, 2025

   · 

  1 min read

   · 

  BioSpace Insights
• 

  CDC

  Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy

  During a hearing in front of the Senate’s HELP committee, Susan Monarez addressed her controversial firing and recalled a conversation where Health Secretary Robert F. Kennedy Jr. allegedly said that “CDC employees were killing children and they don’t care.”

  September 17, 2025

   · 

  4 min read

   · 

  Heather McKenzie